Cancer vaccines : sixth international symposium /
محفوظ في:
| مؤلف مشترك: | |
|---|---|
| مؤلفون آخرون: | , , |
| التنسيق: | أعمال مؤتمر كتاب |
| اللغة: | English |
| منشور في: |
Boston, MA :
Published by Blackwell Pub. on behalf of the New York Academy of Sciences,
2009.
|
| سلاسل: | Annals of the New York Academy of Sciences ;
v. 1174. |
| الموضوعات: | |
| الوصول للمادة أونلاين: | Publisher description |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
جدول المحتويات:
- Some scientific and organizational challenges in cancer immunology
- The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells
- Brain tumor immunotherapy with type-1 polarizing strategies
- Harnessing human dendritic cell subsets to design novel vaccines
- Dendritic cell-based vaccines for pancreatic cancer and melanoma
- Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers
- Witch hunt against tumor cells enhanced by dendritic cells
- Harnessing CD1D-restricted t cells toward antitumor immunity in humans
- Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53-/- mice
- Targets of protective tumor immunity
- Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer
- Harnessing dendritic cells to generate cancer vaccines
- Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells
- Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model
- Hematopoietic stem and progenitor cells and the inflammatory response.